Moleculin Biotech
MBRX
MBRX
31 hedge funds and large institutions have $5.16M invested in Moleculin Biotech in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+7
Holders Change %
+29.17%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Millennium Management
New York
|
$237K |
| 2 |
2
Renaissance Technologies
New York
|
$1.04M |
| 3 |
3
Jane Street
New York
|
$42K |
| 4 |
4
Bank of New York Mellon
New York
|
$78K |
| 5 |
ARTA
5
A.R.T. Advisors
New York
|
$31K |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$2.89M |
| 2 |
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
| 3 |
3
BlackRock
New York
|
$118K |
| 4 |
ACS
4
Archford Capital Strategies
Swansea,
Illinois
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
APA
26
American Portfolios Advisors
Holbrook,
New York
| $2.22K | – | – | – |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2K | +$1.04K | +12 | +109% |
|
28
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $1K | – | – | – |
|
|
GRP
29
Global Retirement Partners
San Rafael,
California
| $1K | – | – | – |
|
|
PWMG
30
Prestige Wealth Management Group
Flemington,
New Jersey
| $1K | – | – | – |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| $1K | +$1K | +6 | New |
|
|
32
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$20K | -180 | Closed |
|
|
ACS
33
Archford Capital Strategies
Swansea,
Illinois
| – | -$4K | -33 | Closed |
|